{
  "ticker": "EW",
  "year": 2024,
  "quarter": 2,
  "last_updated": "2025-04-19T08:46:13.654982",
  "count": 337,
  "transactions": [
    {
      "id": 52476,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 52482,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 73137,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 73143,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 95921,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 95927,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 120833,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 120839,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 147744,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 147750,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 176745,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 176751,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 52429,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 73086,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 95868,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 120776,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 147686,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176687,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 52479,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 73140,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 95924,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 120836,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 147747,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 176748,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 34262,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 52427,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 73084,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 95866,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 120774,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 147684,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 176685,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 34263,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 34268,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 34272,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 34286,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 34298,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 34299,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 34306,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 34320,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 52428,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 52434,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 52438,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 52452,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 52464,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 52465,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 52472,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 52489,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 73085,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 73091,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 73095,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 73110,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 73124,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 73125,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 73133,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 73151,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 95867,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 95873,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 95877,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 95893,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 95908,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 95909,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 95917,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 95935,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 120775,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 120783,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 120787,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 120805,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 120820,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 120821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 120829,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 120847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 147685,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 147693,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 147697,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 147716,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 147731,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 147732,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 147740,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 147758,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 176686,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 176694,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 176698,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 176717,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 176732,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 176733,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 176741,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 176759,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 34312,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 52480,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 73141,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 95925,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 120837,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 147748,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 176749,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 34267,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 34284,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 34291,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 34294,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 34295,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 34314,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 34316,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 52433,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 52450,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 52457,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 52460,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 52461,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 52483,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 52485,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 73090,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 73108,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 73116,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 73120,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 73121,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 73145,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 73147,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 95872,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 95891,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 95899,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 95903,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 95905,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 95929,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 95931,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 120782,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 120803,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 120811,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 120815,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 120817,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 120841,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 120843,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 147692,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 147714,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 147722,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 147726,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 147728,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 147752,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 147754,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 176693,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 176715,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 176723,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 176727,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 176729,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 176753,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 176755,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 34266,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 34271,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 34277,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 34282,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 34304,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 34310,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 34311,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 34313,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 34318,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 34321,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 52432,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 52437,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 52443,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 52448,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 52470,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 52477,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 52478,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 52481,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 52487,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 52490,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 73089,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 73094,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 73101,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 73106,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 73130,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 73138,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 73139,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 73142,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 73149,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 73152,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 95871,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 95876,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 95883,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 95889,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 95914,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 95922,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 95923,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 95926,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 95933,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 95936,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 120780,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 120786,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 120794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 120801,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 120826,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 120834,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 120835,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 120838,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 120845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 120848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 147690,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 147696,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 147704,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 147712,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 147737,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 147745,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 147746,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 147749,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 147756,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 147759,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 176691,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 176697,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 176705,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 176713,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 176738,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 176746,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 176747,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 176750,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 176757,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 176761,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 34264,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 34269,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 34285,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 34289,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 34290,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 34297,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 34305,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 34315,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 34319,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 52430,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 52435,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 52451,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 52455,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 52456,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 52463,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 52471,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 52484,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 52488,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 73087,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 73092,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 73109,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 73113,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 73115,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 73123,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 73131,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 73146,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 73150,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 95869,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 95874,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 95892,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 95896,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 95898,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 95907,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 95915,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 95930,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 95934,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 120778,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 120784,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 120804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 120808,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 120810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 120819,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 120827,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 120842,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 120846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 147688,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 147694,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 147715,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 147719,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 147721,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 147730,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 147738,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 147753,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 147757,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 176689,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 176695,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 176716,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 176720,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 176722,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 176731,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 176739,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 176754,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 176758,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 34274,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52440,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73097,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 95879,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 120790,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 147700,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 176701,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34322,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 52491,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 73153,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 95937,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 120849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 147760,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 176762,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 34288,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 52454,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 73112,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 95895,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 120807,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 147718,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 176719,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 19864,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 34309,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 52475,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 73136,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 95920,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 120832,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 147743,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 176744,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 19848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 19855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 34276,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 34292,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 52442,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 52458,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 73099,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 73117,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 95881,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 95900,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 120792,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 120812,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 147702,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 147723,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 176703,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 176724,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 19845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34270,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52436,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73093,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 95875,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 120785,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 147695,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 176696,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19863,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 34308,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 52474,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 73135,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 95919,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 120831,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 147742,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 176743,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    }
  ]
}